Show results for
Refine by
Balloons Balloon Catheters Equipment Supplied In Singapore
11 equipment items found
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
The control you need to create a predictable, uniform dilatation. Chocolate is designed to reduce vessel trauma by providing a balloon inflation that is*: Predictable, Controlled, ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
The GliderXtreme PTA Balloon Catheter utilizes advanced technology designed to target complex lesions in the distal peripheral vasculature. The innovative features of GliderXtreme™ produce a balloon catheter with exceptional pushability and crossability, providing physicians with the confidence needed to begin and finish ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
The Glider PTCA Balloon Catheter is the only torqueable angioplasty balloon catheter. Combined with its unique balloon shape and state of the art tip technology, the Glider™ is designed to cross through tight lesions and stent struts even in conditions where other balloons are challenged. ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
From the Glider family of balloons, the GliderfleX® PTA Balloon Catheter is designed to support a broad range of challenging angioplasty needs. This high performance Over-The-Wire (OTW) balloon features exceptional maneuverability and crossability. Combined with rapid inflation/ deflation times and controlled ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
Designed to deliver optimal results without a permanent implant. Chocolate® represents a breakthrough in PTA design. Its unique nitinol constraining structure is designed to provide atraumatic dilatation in the treatment of blocked arteries. Less trauma = Better acute ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
Designed for below the knee interventions: BioPath 014 is a drug-eluting balloon dilatation catheter designed for percutaneous transluminal angioplasty (PTA) and has been optimized for the treatment of patients with peripheral arterial disease. BioPath 014 is intended for infrapopliteal interventions below the knee. This paclitaxel-eluting ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
BioPath 035 is a drug-eluting balloon dilatation catheter designed for percutaneous transluminal angioplasty (PTA) and has been optimized for the treatment of patients with peripheral arterial disease. BioPath 035 is intended for peripheral interventions above the knee. This paclitaxel-eleluting balloon feature a proprietary shellac coating ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
Take the Fast Track to Superior Patient Outcomes: The advanced catheter technology of Powerline is designed to offer the right balance of PUSH, TRACK and CROSS to ensure optimal balloon placement and ...
Manufactured by:Genesis MedTech based inSingapore City, SINGAPORE
The Chocolate Touch drug-coated balloon is the world’s first balloon catheter that combines therapeutic agent delivery with the next generation of controlled dilation angioplasty technique, for the treatment of peripheral vascular diseases. It is designed with the aim to provide patients suffering from peripheral vascular disease with a ...
Manufactured by:QT Vascular Ltd. based in, SINGAPORE
The pillows and grooves of the Chocolate® platform were designed to minimize vessel wall trauma. This unique platform has been demonstrated to reduce flow limiting dissections and bail-out stenting. Chocolate Touch® is coated with the drug paclitaxel for improved long-term outcomes. It is indicated to treat peripheral vascular disease and does not require ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
The use of the BioStream PTCA catheter is indicated for patients with discrete lesions of the coronary arteries with a reference vessel diameter of 1.50 to 4.00 mm for the purpose of improving the coronary lumen diameter. The BioStream PTCA catheter is indicated for the dilatation of the affected segments of a coronary artery or a coronary bypass in order to ...
